Abstract
Pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) involves the use of antiretroviral drugs to reduce the risk of HIV infection. Research has indicated an increase in the incidence of sexually transmitted infections (STIs), particularly bacterial ones, among individuals using PrEP. In this context, saliva emerges as a valuable biological fluid for identifying biomarker…